Amit Hazan
Stock Analyst at Goldman Sachs
(2.13)
# 2,793
Out of 4,876 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $131.11 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $6.84 | -63.45% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.90 | +900.00% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $11.37 | -29.64% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $45.96 | +37.08% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $171.31 | +58.78% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $12.53 | +35.67% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $19.54 | +2,126.77% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $57.53 | -23.52% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $77.95 | -6.35% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $30.43 | +74.17% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $31.74 | +79.58% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $11.09 | -14.34% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $134.20 | -22.50% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $11.47 | +423.10% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $86.23 | +33.36% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $394.87 | -62.01% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $106.84 | -56.94% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $542.16 | -55.42% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $91.74 | +92.94% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $152.85 | -3.83% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.36 | +187.82% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $131.11
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $6.84
Upside: -63.45%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.90
Upside: +900.00%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $11.37
Upside: -29.64%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $45.96
Upside: +37.08%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $171.31
Upside: +58.78%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $12.53
Upside: +35.67%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $19.54
Upside: +2,126.77%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $57.53
Upside: -23.52%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $77.95
Upside: -6.35%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $30.43
Upside: +74.17%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $31.74
Upside: +79.58%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $11.09
Upside: -14.34%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $134.20
Upside: -22.50%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $11.47
Upside: +423.10%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $86.23
Upside: +33.36%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $394.87
Upside: -62.01%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $106.84
Upside: -56.94%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $542.16
Upside: -55.42%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $91.74
Upside: +92.94%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $152.85
Upside: -3.83%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.36
Upside: +187.82%